EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in primary glomerulonephritis

Betsy Ellison, Ruzaika Cader, Lisa Willcocks

British Journal of Hospital Medicine · 2024

DOI: 10.12968/hmed.2024.0044 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Hospital Medicine, 2024. Verfasst von Betsy Ellison und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Hauptthemen laut MEDLINE: Glomerulonephritis, Glomerulosclerosis, Focal Segmental, Glomerulonephritis, IGA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary glomerulonephritis comprises several renal-limited diseases that can cause haematoproteinuria, chronic kidney disease, nephrosis and end stage kidney disease. The most common of these are IgA nephropathy (IgAN), primary membranous nephropathy (PMN), Focal Segmental Glomerulosclerosis (FSGS) and Minimal Change Disease (MCD). Although rare, these diseases cause a significant burden to health care systems, given the high cost of treating End Stage Kidney Disease (ESKD) with dialysis or transplantation. Until recently, the pathogenesis of primary gloerulonephritis has remained obscure. However, recent advances in understanding of how these diseases evolve has led to the introduction of novel therapeutic agents. Trials are underway or have recently completed that have huge implications for the standard of care for the primary glomerulonephritidies, and should dramatically reduce the number of patients who progress onto end stage kidney disease. This article reviews the international Kidney Disease Improving Global Outcomes (KDIGO) guidelines for the treatment of IgAN, PMN, FSGS and MCD, as well as recent research on pathogenesis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlomerulonephritisGlomerulosclerosis, Focal SegmentalGlomerulonephritis, IGAHumansGlomerulonephritis, MembranousNephrosis, LipoidImmunosuppressive AgentsPractice Guidelines as Topic

Stichwörter der Autor:innen

Focal segmental glomerulosclerosisIgA nephropathyMembranous glomerulonephritisMinimal change disease

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Nephrology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Zitieren

APA

Ellison, B., Cader, R., & Willcocks, L. (2024). Advances in primary glomerulonephritis. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2024.0044

Vancouver

Ellison B, Cader R, Willcocks L. Advances in primary glomerulonephritis. British Journal of Hospital Medicine. 2024. doi:10.12968/hmed.2024.0044

BibTeX
@article{Ellison2024,
  author = {Ellison, Betsy and Cader, Ruzaika and Willcocks, Lisa},
  title = {Advances in primary glomerulonephritis},
  journal = {British Journal of Hospital Medicine},
  year = {2024},
  doi = {10.12968/hmed.2024.0044}
}
Kostenlos starten →